×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world’s major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Report Name

New Tea Market Size, Share, Trends, Growth Outlook, and Opportunities to 2032- By Type (Cheese Tea, Fruit-based Tea, Others), By Sales Channel (Online, Offline), Companies and Countries Report

Global New Tea Market Size is valued at $XX Million in 2024 and is forecast to register a growth rate (CAGR) of 12.3% to reach $XX Million by 2032.

Published On: October, 2024  |   Report Code: USD00031235  |   No. of Pages: 186

Neuropeptide Y Receptor Market Size, Share, Trends, Growth Outlook, and Opportunities to 2032- By Product (Food Grade, Pharmaceutical Grade), By End-User (Medicine, Food Additives, Others), Companies and Countries Report

Global Neuropeptide Y Receptor Market Size is valued at $XX Million in 2024 and is forecast to register a growth rate (CAGR) of 6.8% to reach $XX Million by 2032.

Published On: October, 2024  |   Report Code: USD00031234  |   No. of Pages: 184

Infant and Kids Probiotics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2032- By Form (Liquid, Powder, Chewable, Others), By Distribution Channel (Retail Pharmacies, Departmental Stores, Supermarket/Hypermarket, E-commerce), Companies and Countries Report

Global Infant and Kids Probiotics Market Size is valued at $4.8 Billion in 2024 and is forecast to register a growth rate (CAGR) of 5.6% to reach $7.4 Billion by 2032.

Published On: October, 2024  |   Report Code: USD00030947  |   No. of Pages: 188

Antiemetics Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Type (Serotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Others), By Application (Chemotherapy, Gastroenteritis, Post Operative Surgery, Others), By End-user ( Hospital & Clinics, Retail Pharmacy, Others), Countries and Companies Report

Antiemetics Drugs Market is projected to register a 6.4% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00012047  |   No. of Pages: 190

Antidote Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Chemical Antidote, Physical Antidote, Pharmacological antidote), By Route of Administration (Oral, Topical, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospital, Homecare, Specialty Clinics, Others), Countries and Companies Report

Antidote Market is projected to register a 8.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00012041  |   No. of Pages: 185

Sickle Cell Disease Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Type (Hydroxyurea, Oxybryta, Adakveo, Others), By Type (Sickle Cell Anemia, HbSC, Others), By Route of Administration (Oral, Parenteral), Countries and Companies Report

Sickle Cell Disease Treatment Market is projected to register a 18.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00012038  |   No. of Pages: 192

Primary Biliary Cholangitis Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug, Obeticholic Acid, Ursodeoxycholic Acid, Others), By Distribution Channel, Hospital Pharmacies, Drugs Stores and Retail Pharmacies, Online Pharmacies), Countries and Companies Report

Primary Biliary Cholangitis Therapeutics Market is projected to register a 7.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00012021  |   No. of Pages: 186